Status:
COMPLETED
Telemedicine vs. Face-to-Face Cancer Genetic Counseling
Lead Sponsor:
Duke University
Collaborating Sponsors:
Susan G. Komen Breast Cancer Foundation
Conditions:
Hereditary Breast and Ovarian Cancer Syndrome
Lynch Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cancer genetic counseling (CGC) has been found to have "substantial" benefits for individuals with breast cancer and their family members; it has been deemed by multiple organizations as "standard of ...
Eligibility Criteria
Inclusion
- Individuals referred for cancer genetic counseling (e.g., by medical oncologist, primary care physician or self) in one of 4 oncology clinics: Gibson Cancer Center in Lumberton, NC; Scotland Cancer Treatment Center in Laurinburg, NC; Johnston Cancer Center in Smithfield, NC; and Maria Parham Cancer Center in Henderson, NC.
- Willing to be randomized to receive counseling via telemedicine or face-to-face.
Exclusion
- Referred for cancer genetic counseling from any clinic other than the 4 listed above.
- Unwilling to be randomized to receive counseling via telemedicine or face-to-face.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00609505
Start Date
August 1 2008
End Date
April 1 2011
Last Update
February 22 2012
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Maria Parham Medical Center
Henderson, North Carolina, United States, 27536
2
Scotland Cancer Treatment Center
Laurinburg, North Carolina, United States, 28352
3
Gibson Cancer Center
Lumberton, North Carolina, United States, 28358
4
Johnston Cancer Center
Smithfield, North Carolina, United States, 27577